Cowen & Co. analyst issues MARKET PERFORM recommendation for MDLZ on October 17, 2023 11:00AM ET. The previous analyst recommendation was Outperform.MDLZ was trading at $63.355 at issue of the...
Wolfe Research analyst issues OUTPERFORM recommendation for MDLZ on October 17, 2023 11:00AM ET. MDLZ was trading at $63.355 at issue of the analyst recommendation.The overall analyst consensus : BUY.Current...
UBS analyst issues BUY recommendation for MDLZ on October 17, 2023 11:00AM ET. The previous analyst recommendation was Neutral.MDLZ was trading at $63.355 at issue of the analyst recommendation.The overall...
Cantor Fitzgerald analyst issues NEUTRAL recommendation for MDLZ on October 17, 2023 11:00AM ET. MDLZ was trading at $63.34 at issue of the analyst recommendation.The overall analyst consensus : BUY.Current...
Oppenheimer analyst issues OUTPERFORM recommendation for MDLZ on October 17, 2023 11:00AM ET. MDLZ was trading at $63.355 at issue of the analyst recommendation.The overall analyst consensus : BUY.Current analyst...
Stephens analyst issues OVERWEIGHT recommendation for MDLZ on October 17, 2023 11:00AM ET. MDLZ was trading at $63.34 at issue of the analyst recommendation.The overall analyst consensus : BUY.Current analyst...
Raymond James analyst issues BUY recommendation for LII on October 17, 2023 07:57AM ET. LII was trading at $377.3 at issue of the analyst recommendation.The overall analyst consensus : BUY.Current...
Exane BNP Paribas analyst issues OUTPERFORM recommendation for MDLZ on October 17, 2023 03:57AM ET. The previous analyst recommendation was Neutral.MDLZ was trading at $62.62 at issue of the analyst...
Cantor Fitzgerald analyst issues NEUTRAL recommendation for REGN on October 16, 2023 01:00PM ET. The previous analyst recommendation was Neutral.REGN was trading at $843.04 at issue of the analyst recommendation.The...
Morgan Stanley analyst issues OVERWEIGHT recommendation for LII on October 16, 2023 09:27AM ET. The previous analyst recommendation was Overweight.LII was trading at $379.07 at issue of the analyst recommendation.The...
